Novartis

Novartis Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Novartis (NOVN.SW) as of Nov 16, 2026 is 116.51. In the previous year, Cash Conversion Cycle (CCC) was 97.11 — a change of 19.97% (higher).

Cash Conversion Cycle

116.51

YoY

19.97%

Last updated:

Cash Conversion Cycle (CCC) of Novartis is 2025 116.51 . Cash Conversion Cycle (CCC) of Novartis was 2024 97.11 . It decreases by 19.97% higher compared to the previous year.

The Novartis Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
120.23 USD
Jan 1, 2019
90.60 USD
Jan 1, 2020
115.56 USD
Jan 1, 2021
116.26 USD
Jan 1, 2022
147.17 USD
Jan 1, 2023
97.19 USD
Jan 1, 2024
97.11 USD
Jan 1, 2025
116.51 USD
The Novartis Cash Conversion Cycle history
YEARCash Conversion CycleYoY
116.51+19.97%
97.11-0.08%
97.19-33.96%
147.17+26.59%
116.26+0.60%
115.56+27.56%
90.60-24.65%
120.23-10.49%
134.33+30.16%
103.21+22.10%
84.53+1.35%
83.40—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novartis Stock analysis

What does Novartis do? Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novartis stock

Cash Conversion Cycle (CCC) of Novartis is 116.51 in 2025.

Cash Conversion Cycle (CCC) of Novartis changed from 97.11 to 116.51, representing a 19.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Novartis since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Novartis with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Novartis

All Key Metrics — Novartis